| Product Name | MF | CAS | Details |
|---|
| Aoa-KDEL-OH | Details |
| Filipin III | C35H58O11 | 480-49-9 | Details |
| 2,3,5,6-Tetraaminocyclohexa-2,5-diene-1,4-dione | C6H8N4O2 | 1128-13-8 | Details |
| Ghrelin antibody | Details |
| N,N'-[(2,2'-dimethyl[1,1'-biphenyl]-3,3'-diyl)bis[methyleneoxy(6-methoxy-2,5-pyridinediyl)methyleneimino-2,1-ethanediyl]]bis-acetami de | C38H48N6O6 | 2182653-84-3 | Details |
| 2-n-Propylpyridine | C8H11N | 622-39-9 | Details |
| 1-(3,5-Dimethylpiperazin-1-yl)ethan-1-one | C8H16N2O | 250739-61-8 | Details |
| 5-Bromo-3-(4-methoxyphenyl)-1,2-oxazole | C10H8BrNO2 | 51726-00-2 | Details |
| (2Z)-3-[(4-Methylphenyl)sulfanyl]prop-2-enoic acid | C10H10O2S | 710-37-2 | Details |
| Betamethasone 21-o-ethyl carbonate | C25H33FO7 | 52619-05-3 | Details |
| tert-butyl 1-(aminomethyl)-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate | C11H20N2O3 | 1357351-98-4 | Details |
| Yunaconitine | C35H49NO11 | 70578-24-4 | Details |
| Lumiracoxib | C15H13ClFNO2 | 220991-20-8 | Details |
| (5,6-Dimethoxypyridin-2-yl)methanol | C8H11NO3 | 59081-38-8 | Details |
| 4-((5-Bromopyridin-2-yl)amino)-4-oxobutanoic acid | C9H9BrN2O3 | 188011-69-0 | Details |
| [3-Methyl-4-(methylsulfanyl)phenyl]methanamine | C9H13NS | 1178916-64-7 | Details |
| 6-Azabicyclo[3.2.1]octan-3-one hydrochloride | C7H12ClNO | 1378821-66-9 | Details |
| 3-Bromo-2-chloroprop-1-ene | C3H4BrCl | 4860-96-2 | Details |
| (4-Chlorophenyl)(4-methylmorpholin-2-yl)methanamine | C12H17ClN2O | 1423028-20-9 | Details |
| 2,4-Dihydro-2-Methyl-5-(Trifluoromethyl)-3H-Pyrazol-3-One | C5H5F3N2O | 1481-02-3 | Details |
| 3-Mercapto-1-hexanol | C6H14OS | 51755-83-0 | Details |
| 2-(Trifluoromethyl)pyrimidin-5-ol | C5H3F3N2O | 100991-09-1 | Details |
| TMCO4 Blocking Peptide | Details |
| 6-Chloro-9-methylpurine | C6H5ClN4 | 2346-74-9 | Details |
| 4,4'-Dimethylbianthrone | C30H20O2 | 24541-19-3 | Details |
| 1-(2-Pyrrolidinylmethyl)azepane dihydrochloride | C11H23ClN2 | 1219964-19-8 | Details |
| 5-(Methoxycarbonyl)-2-methylbenzoic acid | C10H10O4 | 65399-17-9 | Details |
| N6-Benzoyl-3'-O-tert-butyldimethylsilyl-2'-deoxyadenosine | C23H31N5O4Si | 51549-40-7 | Details |
| 1-Methyl-1H-pyrazolo[4,3-c]pyridin-3-amine | C7H8N4 | 1556454-14-8 | Details |
| IL21 antibody | Details |
| 1,3-Dimethyl-1H-pyrazolo[3,4-b]pyridin-4-ol | C8H9N3O | 1057670-30-0 | Details |
| HSV-1-amide UL 26 Open Reading Frame (242-255) | C80H117N21O20S | 396716-24-8 | Details |
| (1H-Indazol-4-yl)methanamine | C8H9N3 | 944898-72-0 | Details |
| 5-bromo-2-fluoro-4-(trifluoromethyl)benzoic acid | C8H3BrF4O2 | 1699741-92-8 | Details |
| 2-Sulfamoylacetic acid | C2H5NO4S | 17551-00-7 | Details |
| Bis[(1,3-thiazol-5-yl)methyl]amine trihydrochloride | 2138169-09-0 | Details |
| Pabulenol | C16H14O5 | 33889-70-2 | Details |
| Cellulase, powder | NULL | 9012-54-8 | Details |
| H-NPATTNQTEFER-OH | Details |
| 3-Benzyl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-7-ol | C11H9N5O | 21324-31-2 | Details |
| Methyl 2-Chloro-6-Methoxypyrimidine-4-Carboxylate | C7H7ClN2O3 | 127861-30-7 | Details |
| Ethyl 1,4,6,7-tetrahydropyrano[4,3-c]pyrazole-3-carboxylate | C9H12N2O3 | 518990-21-1 | Details |
| SHA 68 | C26H24FN3O3 | 847553-89-3 | Details |
| Ibrutinib d5 | C25H24N6O2 | 1553977-17-5 | Details |
| [4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanyl-methanone | C19H21N5O4 | 19216-56-9 | Details |
| 3-(tert-Butyl)-4-methoxybenzaldehyde | C12H16O2 | 107430-92-2 | Details |
| Casein Kinase II Receptor Peptide | C46H75N15O23 | 198481-81-1 | Details |
| SLC45A3 antibody | Details |
| 1-(Difluoromethyl)-1H-imidazole-4-carboxylic acid | C5H4F2N2O2 | 2098794-95-5 | Details |
| 5'-O-Benzoyl-2'-deoxy-N2-isobutyrylguanosine 3'-CE phosphoramidite | C30H40N7O7P | Details |
| RTKN antibody | Details |
| Trans-4-trifluoromethoxy-cyclohexylamine hydrochloride | C7H13ClF3NO | 2376143-36-9 | Details |
| b-Cellobiosyl azide | C12H21N3O10 | 69194-62-3 | Details |
| tert-Butyl 3-({[(4-methyl-1,3-thiazol-5-yl)methyl]amino}methyl)pyrrolidine-1-carboxylate | C15H25N3O2S | 1803608-82-3 | Details |
| 3-Cyclobutyl-4-nitro-1H-pyrazole | C7H9N3O2 | 1374830-12-2 | Details |
| 5-Chloro-2-methoxy-4-methylnitrobenzene | C8H8ClNO3 | 101080-03-9 | Details |
| NNC45-0781 | C27H29NO3 | 207277-66-5 | Details |
| 1-(1-{5H,6H,7H,8H,9H-[1,2,4]Triazolo[4,3-a]azepin-3-yl}ethyl)-1H-pyrazol-4-amine hydrochloride | C12H19ClN6 | 1431964-49-6 | Details |
| 5-methyl-3-((4-(phenylamino)phenyl)amino)cyclohex-2-en-1-one | C19H20N2O | 1022488-66-9 | Details |
| Ethyl 4-methyl-2-oxopiperidine-3-carboxylate | C9H15NO3 | 102943-15-7 | Details |
| 6-Bromo-5-methyl-3H-imidazo[4,5-b]pyridine-2-thiol | C7H6BrN3S | 104685-80-5 | Details |
| (4-Acetyl-[1,4]diazepan-1-yl)-acetic acid | C9H16N2O3 | 1274048-50-8 | Details |
| H-YTVKYPNL-OH | Details |
| HNRNPU Blocking Peptide | Details |
| 5-{[(2-Chloropyridin-4-yl)amino]methylidene}-2,2-dimethyl-1,3-dioxane-4,6-dione | C12H11ClN2O4 | 1018812-97-9 | Details |
| (2R)-1-Fluoro-3-methoxypropan-2-amine hydrochloride | 2361610-41-3 | Details |
| Histone H3 (1-15) K4Me3, K9Ac, pS10 | Details |
| 4-Amino-1-benzyl-5-methylpyrrolidin-2-one hydrochloride | C12H17ClN2O | 1803567-17-0 | Details |
| 4-Hydroxy-1-methyl-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid | C8H7N3O3 | 37800-04-7 | Details |
| 2H-Benzo[b][1,4]oxathiepin-3(4H)-one | C9H8O2S | 112632-24-3 | Details |
| H-ERCPHRPIL-OH | Details |
| CPI-455 HCl | C16H15ClN4O | 2095432-28-1 | Details |
| 3-[3-(Pyrrolidine-1-carbonyl)-1H-pyrazol-1-yl]propanoic acid | C11H15N3O3 | 1006435-21-7 | Details |
| 2-Acetyl-5-fluorobenzonitrile | C9H6FNO | 1363508-10-4 | Details |
| Sulfuric acid, tert-butyl N-[(1-carbamimidoylpiperidin-4-yl)methyl]carbamate | 2172493-89-7 | Details |
| H-VVLGDQDLK^-OH | Details |
| 1-(diphenylmethyl)-4-(1-phenylcyclopentanecarbonyl)piperazine | C29H32N2O | 1024169-50-3 | Details |
| NUP155 Blocking Peptide | Details |
| 2-[({5,7-Dimethylimidazo[1,2-a]pyrimidin-2-yl}methyl)sulfanyl]propanoic acid | C12H15N3O2S | 380572-61-2 | Details |
| (2,3,5-Trifluorophenyl)hydrazine hydrochloride | C6H6ClF3N2 | 1909312-01-1 | Details |
| 1-(3,4-Diethoxyphenyl)ethan-1-amine hydrochloride | C12H20ClNO2 | 390815-37-9 | Details |
| 3-(3-Bromophenyl)oxetan-3-ol | C9H9BrO2 | 1379811-98-9 | Details |
| 1-(2-Ethylphenyl)-1H-1,2,3-triazole-4-carboxylic acid | C11H11N3O2 | 1042604-57-8 | Details |
| (2S)-1-Amino-3-(piperidin-1-yl)propan-2-ol dihydrochloride | C8H20Cl2N2O | 1909287-35-9 | Details |
| N-(2-Methylpropyl)cyclohexanamine hydrochloride | C10H22ClN | 99863-04-4 | Details |
| Methyl 1,2,3,4-Tetrahydroquinoline-6-carboxylate | C11H13NO2 | 185057-00-5 | Details |
| 2-[2-(Aminomethyl)cyclohexyl]-1λ6,2-thiazolidine-1,1-dione, acetic acid | 2225136-29-6 | Details |
| 5-Oxa-9-azaspiro[3.5]nonane | C7H13NO | 2137579-91-8 | Details |
| 3-[(4-Fluorophenyl)methyl]-2-methyl-4,9-dioxo-1-(phenylmethyl)-1H-naphth[2,3-d]imidazolium chloride | C26H20ClFN2O2 | 2361988-77-2 | Details |
| 1-[(3-Chlorophenyl)methyl]-3-methyl-1H-pyrazol-5-amine hydrochloride | 1431962-56-9 | Details |
| H-KWKLFKKIGAVLKVL-NH2 | Details |
| [4-(Azocan-1-ylmethyl)phenyl]methanamine | C15H24N2 | 115174-12-4 | Details |
| rac-(2R,3R)-2-Phenyloxolane-3-carbohydrazide | C11H14N2O2 | 1807912-18-0 | Details |
| ABCA4 antibody | Details |
| H-MHRQETVDCLKKFN-NH2 | Details |
| 2-{[(tert-butoxy)carbonyl]amino}pyridine-4-carboxylic acid | C11H14N2O4 | 365412-92-6 | Details |
| Recombinant Human FGF R1alpha (IIIc) | Details |
| N-[(1-Methyl-1H-1,2,3-triazol-4-yl)methyl]cyclopropanamine hydrochloride | 2155852-64-3 | Details |
| (9AR)-Octahydropyrazino[2,1-c][1,4]oxazine | C7H14N2O | 508241-14-3 | Details |
| 3,3-Dimethylbutane-1-sulfonyl fluoride | C6H13FO2S | 372-61-2 | Details |
| Product Total： Product Page： | ||||
| 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 | ||||